These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 8303307
21. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation. Dang LH, Lien LL, Benacerraf B, Rock KL. J Immunol; 1993 May 15; 150(10):4206-17. PubMed ID: 8482833 [Abstract] [Full Text] [Related]
22. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions. Cohen CJ, Denkberg G, Lev A, Epel M, Reiter Y. J Mol Recognit; 2003 May 15; 16(5):324-32. PubMed ID: 14523945 [Abstract] [Full Text] [Related]
23. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes. Seliger B, Harders C, Wollscheid U, Staege MS, Reske-Kunz AB, Huber C. Exp Hematol; 1996 Sep 15; 24(11):1275-9. PubMed ID: 8862437 [Abstract] [Full Text] [Related]
24. T-cells behaving badly: structural insights into alloreactivity and autoimmunity. Ely LK, Burrows SR, Purcell AW, Rossjohn J, McCluskey J. Curr Opin Immunol; 2008 Oct 15; 20(5):575-80. PubMed ID: 18678247 [Abstract] [Full Text] [Related]
26. MHC class II compartments: specialized organelles of the endocytic pathway in antigen presenting cells. Pieters J. Biol Chem; 1997 Aug 15; 378(8):751-8. PubMed ID: 9377469 [Abstract] [Full Text] [Related]
28. MHC class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design. Zeng G. J Immunother; 2001 Aug 15; 24(3):195-204. PubMed ID: 11394496 [Abstract] [Full Text] [Related]
29. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Immunol Rev; 2005 Oct 15; 207():145-57. PubMed ID: 16181333 [Abstract] [Full Text] [Related]
30. Indirect presentation of MHC antigens in transplantation. Shoskes DA, Wood KJ. Immunol Today; 1994 Jan 15; 15(1):32-8. PubMed ID: 8136009 [Abstract] [Full Text] [Related]
31. New tools for antigen delivery to the MHC class I pathway. Morón G, Dadaglio G, Leclerc C. Trends Immunol; 2004 Feb 15; 25(2):92-7. PubMed ID: 15102368 [Abstract] [Full Text] [Related]
32. Quantitative aspects of T-cell recognition: from within the antigen-presenting cell to within the T cell. Bongrand P, Malissen B. Bioessays; 1998 May 15; 20(5):412-22. PubMed ID: 9670814 [Abstract] [Full Text] [Related]
33. Pathways of antigen processing and presentation. Watts C, Powis S. Rev Immunogenet; 1999 May 15; 1(1):60-74. PubMed ID: 11256573 [Abstract] [Full Text] [Related]
34. Diversity & overlap in the mechanisms of processing protein antigens for presentation to T cells. Rajagopal D, Bal V, George A, Rath S. Indian J Med Res; 2004 Aug 15; 120(2):75-85. PubMed ID: 15347856 [Abstract] [Full Text] [Related]
35. The major histocompatibility complex in man. Buc M. Folia Biol (Praha); 1993 Aug 15; 39(5):223-42. PubMed ID: 8206168 [Abstract] [Full Text] [Related]
36. A critical contemplation on the role of heat shock proteins in transfer of antigenic peptides during antigen presentation. Li Z, Srivastava PK. Behring Inst Mitt; 1994 Jul 15; (94):37-47. PubMed ID: 7998912 [Abstract] [Full Text] [Related]
37. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines. Germain RN. Ann N Y Acad Sci; 1995 May 31; 754():114-25. PubMed ID: 7625645 [Abstract] [Full Text] [Related]